Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ingredia is a global life science company specializing in the development and production of innovative milk-derived bioactive ingredients and functional proteins. As a subsidiary of the French dairy cooperative La Prospérité Fermière, the company utilizes advanced fractionation and purification technologies to isolate high-value molecules from milk. Their flagship product, Lactium, is a clinically-proven bioactive peptide used in the nutraceutical industry for stress management and sleep quality improvement. Beyond stress health, Ingredia offers a range of specialized proteins, such as Prodiet and Osteum, which target muscle mass preservation and bone health, respectively. The company is recognized for its commitment to scientific validation, sustainable sourcing, and providing technical expertise to pharmaceutical and food-supplement manufacturers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ingredia Resources.